Exicure

$2.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.48%) Today
+$0.01 (+0.49%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Exicure and other stocks, options, and ETFs commission-free!

About XCUR

Exicure, Inc. Common Stock, also called Exicure, is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. The listed name for XCUR is Exicure, Inc. Common Stock.

CEO
David A. Giljohann
Employees
—
Headquarters
Chicago, Illinois
Founded
2011
Market Cap
193.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
586.00K
High Today
$2.16
Low Today
$1.99
Open Price
$2.13
Volume
877.68K
52 Week High
$3.30
52 Week Low
$0.9573

XCUR Earnings

-$0.12
-$0.08
-$0.03
$0.01
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 8, Pre-Market

You May Also Like

HENOY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure